SCHEMBL8580581

SCHEMBL8580581

O=c1cc(-c2ccc(O)cc2)c2c(O)cc(O)cc2o1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP1LC3B Q9GZQ8 1/20 0.80
▸ SIRT1 Q96EB6 1/20 0.59
▸ ALDH1A1 P00352 8/20 0.59
▸ HPGD P15428 6/20 0.59
▸ MAPT P10636 6/20 0.59
▸ CYP3A4 P08684 6/20 0.59
▸ ALOX15 P16050 5/20 0.59
▸ MEN1 O00255 5/20 0.59
▸ KMT2A Q03164 5/20 0.59
▸ TSHR P16473 4/20 0.59
▸ TP53 P04637 4/20 0.59
▸ CYP2C9 P11712 4/20 0.59
▸ AKR1B1 P15121 4/20 0.59
▸ XDH P47989 4/20 0.59
▸ DAPK1 P53355 4/20 0.59
▸ TDP1 Q9NUW8 4/20 0.59
▸ HDAC6 Q9UBN7 4/20 0.59
▸ ABCG2 Q9UNQ0 4/20 0.59
▸ POLH Q9Y253 4/20 0.59
▸ HSD17B10 Q99714 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30677928 0.89 MAP1LC3B (0.74) MAP1LC3BSIRT1ALDH1A1HPGDMAPT
SCHEMBL29115369 0.89 MAP1LC3B (0.74) MAP1LC3BSIRT1ALDH1A1HPGDMAPT
SCHEMBL3787335 0.89 MAP1LC3B (1.00) MAP1LC3BALDH1A1HPGDMAPTCYP3A4
SCHEMBL29115413 0.88 MAP1LC3B (0.76) MAP1LC3BSIRT1ALDH1A1HPGDMAPT
SCHEMBL29115331 0.86 MAP1LC3B (0.68) MAP1LC3BALDH1A1HPGDMAPTCYP3A4
SCHEMBL30677926 0.86 MAP1LC3B (0.68) MAP1LC3BALDH1A1HPGDMAPTCYP3A4
SCHEMBL3782904 0.84 LMNA (0.67) MAP1LC3BSIRT1ALDH1A1HPGDMAPT
SCHEMBL5679746 0.79 MAP1LC3B (0.73) MAP1LC3BALDH1A1HPGDMAPTCYP3A4
SCHEMBL536984 0.79 ALDH1A1 (0.72) MAP1LC3BALDH1A1HPGDMAPTCYP3A4
SCHEMBL27442679 0.77 CA12 (0.82) ALDH1A1HPGDMAPTCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 — — US disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 — — US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 — — US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 — — US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 — — US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 — — US disclosed
WO-1998025608-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A 4-ARYLCOUMARIN FOR THE TREATMENT OF VIRAL INFECTIONS BIO'S S.R.L. (IT) 1998-06-18 — — WO disclosed
Send feedback